← All indications
Non-alcoholic Fatty Liver Disease
Fatty liver finding without excessive ALCOHOL CONSUMPTION.
Drugs by status
Approved for this indication (3)
Phase 4 trials (54)
- calcitriol
- atorvastatin
- berberine
- exenatide
- metformin
- flax
- alpha-lipoic acid
- vitamin e
- pentoxifylline
- insulin glargine
- icosapent ethyl
- goserelin
- rosuvastatin
- perindopril
- dulaglutide
- amlodipine
- ursodeoxycholic acid
- orlistat
- montelukast
- semaglutide
- glimepiride
- alendronic acid
- empagliflozin
- dapagliflozin
- interferon alpha-1
- pioglitazone
- ezetimibe
- rifampin
- denosumab
- henagliflozin
- +24 more
Phase 3 trials (43)
- cysteamine
- Azemiglitazone
- viusid
- caffeine
- bos-580
- diacerein
- trigonella foenum-graecum
- ginger
- alosetron
- vitamin d3
- lactose
- secukinumab
- lactobacillus helveticus
- curcumin
- hydroxytyrosol
- efruxifermin
- losartan
- cenicriviroc
- diosmetine
- ergocalciferol
- survodutide
- ubiquinone
- selonsertib
- sodium chloride
- phosphatidylcholine
- s-adenosyl methionine
- lanifibranor
- eltrombopag
- oltipraz
- resveratrol
- +13 more
Phase 2 trials (176)
- tqa2225
- curcuma longa
- Streptococcus thermophilus
- cholestyramine
- allogeneic microbiota
- lys006
- bi 1467335
- bifidobacterium breve
- brivanib alaninate
- aln-hsd
- pasteurized a. muciniphila
- nicotinamide
- elobixibat
- aldafermin
- lactobacillus plantarum
- cc-90001
- asc41
- tern-501
- firsocostat
- vigabatrin
- azithromycin
- cagrilintide
- met642
- azd2693
- betaine
- acetylcysteine
- lactobacillus casei
- tirzepatide
- zed1227
- melissa officinalis
- +146 more
Phase 1 trials (82)
Other trials (78)
- ethanol
- mare milk
- hepatitis b vaccine (recombinant)
- snp-612
- pitavastatin
- camu camu
- lipid emulsion
- Desulfovibrio piger
- magnesium
- corn
- maltitol
- acetobacter
- citrulline
- ginseng
- stevia
- docosahexaenoic acid
- ribavirin
- propionibacterium freudenreichii
- maple syrup
- hydrolyzed oyster extract
- lactococcus lactis
- methylcellulose
- salvia
- vitamin c
- simvastatin
- folic acid
- phytosterol
- choline
- schisandra chinensis
- gallate
- +48 more
Organizations
Organization Involved with Phase 4 Indications (65)
- St. Louis University
- Eli Lilly
- The University of Hong Kong
- University of Florida
- Korea University
- GlaxoSmithKline
- Kuhnil Pharmaceutical Co., Ltd.
- Clinical Hospital Centre Rijek, Croatia
- Merck
- Pfizer
- Hangzhou Normal University
- University of London
- Pliva
- Leiden University
- Government of Germany
- National Institutes of Health (NIH)
- University of Missouri
- University of Malaya
- Federal Ministry of Health, Germany
- Xijing Hospital
- Department of Veteran Affairs
- Fudan University
- Boehringer Ingelheim
- University Hospital, Rijeka
- Sun Yat-Sen University
- IlDong Pharmaceutical Co Ltd
- Belupo d.d., Koprivnica, Croatia
- Dutch Donor Feces Bank
- Kanazawa University
- Ruhr University Bochum
- +35 more
Organization Involved with Phase 3 Indications (40)
- Galmed Pharmaceuticals Ltd
- National Nutrition and Food Technology Institute
- Ain Shams University
- Tobira Therapeutics, Inc.
- University of Virginia
- Command Hospital, India
- Changi General Hospital
- Gilead Sciences
- Indiana University
- NHS Lothian
- Catalysis SL
- Bambino Gesù Hospital and Research Institute
- University of Massachusetts
- Asian Institute of Gastroenterology
- University of Edinburgh
- Allergan
- University of Manitoba
- Madrigal Pharmaceuticals
- Abbott
- Rio de Janeiro State University
- PharmaKing
- Galectin Therapeutics Inc.
- Seoul National University
- PPD
- Intercept Pharmaceuticals
- National Center for Complementary and Integrative Health (NCCIH)
- Federal University of Rio de Janeiro
- University of Tehran
- National Autonomous University of Mexico
- Institute of Liver and Biliary Sciences, India
- +10 more
Organization Involved with Phase 2 Indications (184)
- Singapore Bioimaging Consortium
- Ampang Hospital, Malaysia
- University of North Carolina at Chapel Hill
- Shire
- University of Nottingham
- Zydus Discovery DMCC
- Harvard University
- Estimate, GmbH
- AstraZeneca
- University of Washington
- Uppsala University
- Enanta Pharmaceuticals
- Sahlgrenska University Hospital, Sweden
- University of Illinois at Chicago
- Covance
- Corcept Therapeutics
- Exalenz Bioscience LTD.
- Albireo
- Sagimet Biosciences
- Madaus Inc
- Celgene
- Lipocine Inc.
- EA Pharma Co., Ltd.
- Mochida Pharmaceutical Company, Ltd.
- University of Birmingham
- Crolll Gmbh
- ProSciento, Inc.
- Profil GmbH
- ScandiBio Therapeutics AB
- Shanghai Municipal Science and Technology Commission
- +154 more
Organization Involved with Phase 1 Indications (31)
- Parexel
- Shaoguan University
- Autonomous University of Madrid
- Perspectum Diagnostics Ltd
- Blade Therapeutics
- National Institute of General Medical Sciences (NIGMS)
- Hepanova Inc.
- Vanderbilt University
- Sunshine Lake Pharma Co., Ltd.
- CohBar, Inc.
- Government of Malaysia
- University of Cantabria
- Boston University
- Altimmune, Inc.
- Bird Rock Bio, Inc.
- Guangdong Zhongsheng Pharmaceutical Co., Ltd.
- Novotech
- Rivus Pharmaceuticals, Inc.
- Pharmaceutical Research Associates, Inc. (PRA)
- Navidea Biopharmaceuticals
- Jilin University
- Georgetown University
- Icahn School of Medicine at Mount Sinai
- Brown University
- Sciwind Biosciences APAC CO Pty. Ltd.
- University of Oxford
- Arrowhead Pharmaceuticals
- Ohio State University
- Prism Research
- Alnylam Pharmaceuticals
- +1 more
Organization Involved with Other Experimental Indications (56)
- China Medical University
- Instituto Nacional de Cardiologia Ignacio Chavez
- Nutrasource Diagnostics
- Danish Council for Independent Research
- Government of Denmark
- McMaster University
- Hallym University
- University of Calgary
- Federal University of Bahia
- Steno Diabetes Center Copenhagen
- University of Copenhagen
- University of Lausanne
- Medanta - The Medicity
- Canadian Institutes of Health Research (CIHR)
- Rockefeller University
- Ajinomoto
- Zhejiang Medicine Co., Ltd.
- Pronova BioPharma
- Maastricht University
- Federal University of Health Science of Porto Alegre
- Daiwa Pharmaceutical Corporation
- Eurasia Invest Ltd., Kazakhstan
- Wiener Wissenschafts-, Forschungs- und Technologiefonds
- Cornell University
- Medical University of Vienna
- Algatechnologies Ltd.
- R&G Pharma Studies Co.,Ltd.
- BASF
- Azad University
- Bogomolets National Medical University
- +26 more